Hit Mox 625 Tablet is a combination antibiotic formulation containing Amoxycillin 500 mg and Clavulanic Acid 125 mg, designed to combat a broad spectrum of bacterial infections. Amoxycillin, a beta-lactam antibiotic, inhibits bacterial cell wall synthesis, leading to cell lysis and death, while Clavulanic Acid acts as a beta-lactamase inhibitor, preventing enzymatic degradation of Amoxycillin by resistant bacteria. This synergistic action enhances efficacy against beta-lactamase-producing strains, making Hit Mox 625 effective in treating infections caused by susceptible organisms. It is commonly prescribed for respiratory tract infections, urinary tract infections, skin and soft tissue infections, and otitis media. The tablet should be administered orally, preferably at the start of a meal to improve absorption and reduce gastrointestinal discomfort. Dosage and duration depend on the severity and type of infection, as determined by a healthcare professional. Caution is advised in patients with a history of penicillin allergy or hypersensitivity to beta-lactam antibiotics. Common adverse effects include gastrointestinal disturbances such as nausea, diarrhea, and rash. Use during pregnancy and lactation should be under medical supervision. Proper adherence to prescribed therapy is essential to prevent resistance development and ensure optimal clinical outcomes.